LICHEN SIMPLEX CHRONICUS
Clinical trials for LICHEN SIMPLEX CHRONICUS explained in plain language.
Never miss a new study
Get alerted when new LICHEN SIMPLEX CHRONICUS trials appear
Sign up with your email to follow new studies for LICHEN SIMPLEX CHRONICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot could stop relentless itch in rare skin condition
Symptom relief OngoingThis study tests if a drug called dupilumab can reduce severe itching in adults with lichen simplex chronicus, a skin condition that causes intense, persistent itch. About 138 participants will receive either dupilumab or a placebo injection for 24 weeks. The main goal is to see …
Matched conditions: LICHEN SIMPLEX CHRONICUS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 26, 2026 09:14 UTC
-
New hope for relentless itch: drug targets lichen simplex chronicus
Symptom relief OngoingThis study tests if dupilumab injections can reduce severe itching in adults with lichen simplex chronicus, a condition causing thick, itchy skin patches. About 142 participants will receive either dupilumab or a placebo for 24 weeks. The main goal is to see if more people get me…
Matched conditions: LICHEN SIMPLEX CHRONICUS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC